Tim Smole (Author), Bojan Žunkovič (Author), Matej Pičulin (Author), Enja Kokalj (Author), Marko Robnik Šikonja (Author), Matjaž Kukar (Author), Zoran Bosnić (Author), Lars S. Maier (Author), Lazar Velicki (Author), Guy A. MacGowan (Author), Iacopo Olivotto (Author), Nenad Filipović (Author), Djordje G. Jakovljević (Author), Dimitrios I. Fotiadis (Author), Vasileios C. Pezoulas (Author), Nikolaos S. Tachos (Author), Fausto Barlocco (Author), Francesco Mazzarotto (Author), Dejana Popović (Author)

Abstract

Background: Machine learning (ML) and artificial intelligence are emerging as important components of precision medicine that enhance diagnosis and risk stratification. Risk stratification tools for hypertrophic cardiomyopathy (HCM) exist, but they are based on traditional statistical methods. The aim was to develop a novel machine learning risk stratification tool for the prediction of 5-year risk in HCM. The goal was to determine if its predictive accuracy is higher than the accuracy of the state-of-the-art tools. Method: Data from a total of 2302 patients were used. The data were comprised of demographic characteristics, genetic data, clinical investigations, medications, and disease-related events. Four classification models were applied to model the risk level, and their decisions were explained using the SHAP (SHapley Additive exPlanations) method. Unwanted cardiac events were defined as sustained ventricular tachycardia occurrence (VT), heart failure (HF), ICD activation, sudden cardiac death (SCD), cardiac death, and all-cause death. Results: The proposed machine learning approach outperformed the similar existing risk-stratification models for SCD, cardiac death, and all-cause death risk-stratification: it achieved higher AUC by 17%, 9%, and 1%, respectively. The boosted trees achieved the best performing AUC of 0.82. The resulting model most accurately predicts VT, HF, and ICD with AUCs of 0.90, 0.88, and 0.87, respectively. Conclusions: The proposed risk-stratification model demonstrates high accuracy in predicting events in patients with hypertrophic cardiomyopathy. The use of a machine-learning risk stratification model may improve patient management, clinical practice, and outcomes in general.

Keywords

hipertrofična kardiomiopatija;napovedovanje rizika;strojno učenje;umetna inteligenca;hypertrophic cardiomyopathy;risk stratification;machine learning;artificial intelligence;

Data

Language: English
Year of publishing:
Typology: 1.01 - Original Scientific Article
Organization: UL FRI - Faculty of Computer and Information Science
UDC: 004.8:616.12-008.46
COBISS: 71489795 Link will open in a new window
ISSN: 0010-4825
Views: 52
Downloads: 23
Average score: 0 (0 votes)
Metadata: JSON JSON-RDF JSON-LD TURTLE N-TRIPLES XML RDFA MICRODATA DC-XML DC-RDF RDF

Other data

Secondary language: Slovenian
Secondary keywords: hipertrofična kardiomiopatija;napovedovanje tveganja;strojno učenje;umetna inteligenca;
Type (COBISS): Article
Pages: str. 1-9
Issue: Vol. 135
Chronology: Aug. 2021
DOI: 10.1016/j.compbiomed.2021.104648
ID: 16129070
Recommended works:
, s Pythonom do prvega klasifikatorja
, diplomsko delo Visokošolskega strokovnega študijskega programa I. stopnje Strojništvo
, no subtitle data available